Loading...
patent
Ganciclovir derivatives for modulating innate and adaptive immunity and for use in immunotherapy
2017
Compositions and methods for modulating innate and adaptive immunity and for use in immunotherapy are disclosed. In particular, the invention relates to novel ganciclovir derivatives and methods of using them for the treatment of immune-related disorders, including inflammation, autoimmunity, and infections, and neurological disorders, and cancer.
Type
patent
EPO Family ID
58157430
Author(s)
EPFL units
DOI | Country code | Kind code | Date issued |
US9809597 | US | B2 | 2017-11-07 |
US2017050967 | US | A1 | 2017-02-23 |
Available on Infoscience
December 1, 2017
Use this identifier to reference this record